The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate

Pharmacoepidemiology and Drug Safety
John McEwenCathy G Riley

Abstract

To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia. Review of spontaneous reports to the Australian Adverse Drug Reactions Advisory Committee (ADRAC); estimation of incidence using national prescription reimbursement data; concomitant exposure to methotrexate was estimated using three sources of information. ADRAC received 11 reports of pancytopenia (meeting predefined criteria) associated with the use of leflunomide during its first 31 months of marketing. In nine reports, the patients were also taking methotrexate. Estimates of incidence in patients taking leflunomide alone ranged from 1 in 3698 to 1 in 4582 patients exposed; for patients also taking methotrexate the estimates ranged from 1 in 575 to 1 in 822. Use of methotrexate with leflunomide increases the risk of pancytopenia compared with use of leflunomide alone. The haematological toxicity of the combination requires further study.

References

May 1, 1997·Clinical Rheumatology·Y OhosoneY Ikeda
Sep 16, 2000·Acta medica Austriaca·J AuerP Knoflach
Dec 31, 2002·The Annals of Pharmacotherapy·Richard L HillPatrick M Purcell
Jun 10, 2004·The Annals of Pharmacotherapy·Jonathan ChanPeter I Pillans
Jul 17, 2004·British Journal of Clinical Pharmacology·E N Van RoonJ R B J Brouwers

❮ Previous
Next ❯

Citations

Dec 25, 2009·Rheumatology·Mirjam WüsthofCarsten Bokemeyer
Mar 29, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Nicolae LecaConnie L Davis
Apr 8, 2009·Chest·Joseph Paul NesheiwatLaura D Carbone
Jun 6, 2013·Advances in Pharmacological Sciences·Marinella PatanèEmilio Russo
Jul 13, 2016·Drugs & Aging·Su-Ann YeohRichard Hull
May 22, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ruth L Savage
Oct 6, 2012·The Journal of Toxicological Sciences·Sayuri KojimaTakanori Harada
Jun 4, 2019·BMJ Case Reports·Ahmad ArslanSohaib Roomi
Mar 30, 2007·The Medical Journal of Australia·Chris W KelmanDavid A Henry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.